-
Recent Posts:
Recent Comments:
Latest PLoG Posts
- Good to Know: Which Websites Can Reduce Anxiety and Depression? in Work In Progress
- How Understanding Psychosis could have been more credible and trustworthy in Work In Progress
- New obesity medication now available in Canada in Work In Progress
- Cholesterol and coffee ok, plus head transplants soon? in Work In Progress
- The Fatter we Get, the Less We Seem to Notice in Work In Progress
Blog Archives
Cancer Care’s “Culture of Excess”
Category: cancer, Cost-Effectiveness Analysis, Healthcare
Tagged biomarkers, cancer, cancer care, cancer cost, complex adaptive systems, European Multidisciplinary Cancer Congress, FiercePharma, incremental cost-effectiveness ratios, moral hazard, Richard Sullivan, The Huffington Post, The Lancet Oncology
3 Comments
Jessica Wapner is a freelance writer focused mainly on biomedical issues. Her work is published in Scientific American, The New York Times, Slate, Science, Nature Medicine, and elsewhere. Her first book, The Philadelphia Chromosome is forthcoming from The Experiment in May 2013.